A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins

Archives of Internal Medicine

Volumn 159, Issue 17, 1999, Pages 2070-2076

  Crouse III, John R ^a   Morgan, Timothy ^a   Terry, James G ^a   Ellis, Julie ^a   Vitolins, Mara ^a   Burke, Gregory L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LIPID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CASEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOFLAVONES; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; SOYBEAN PROTEINS; TRIGLYCERIDES;

EID: 0033610239     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.17.2070     Document Type: Article

References (37)

1. Gordon T. Further mortality experience among Japanese Americans. Public Health Rep. 1967;82:973-984.
2. Stemmermann GN. Pathology of breast cancer in Japanese women compared to other ethnic groups: a review. Breast Cancer Treat Pep. 1991;189(suppl):S67-S72.
3. Epstein FH, Thom TJ. Coronary heart disease mortality: international differences and time trends. In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. New York, NY: Haymarket Doyma; 1987:51-54.
4. Adlercreutz M. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest. 1990;201 (suppl):3-23.
5. Sack FM, Castelli WP, Donner A, Kass EH. Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med. 1975;292:1148-1151.
6. Sirtori CR, Even R, Lovati MR. Soybean protein diet and plasma cholesterol: from therapy to molecular mechanisms. Ann N Y Acad Sci. 1993;676:188-201.
7. Young VR. Soy protein in relation to human protein and amino acid nutrition. J Am Diet Assoc. 1991;91:828-835.
8. Wiseman H. Role of dietary phyto-estrogens in the protection against cancer and heart disease. Biochem Soc Trans. 1996;24:795-800.
9. Dwyer JT, Goldin BR, Saul N, Gaultin L, Barakat S, Adlerereutz H. Tofu and soy drinks contain phytoestrogens. J Am Diet Assoc. 1994;94:739-743.
10. Anthony MS, Clarkson TB, Hughes CL Jr, Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutrition. 1996;126:43-50.
11. Anthony MS, Clarkson TB, Bullock BC. Soy protein versus soy phytoestrogens (isoflavones) in the prevention of coronary artery atherosclerosis of cynomolgus monkeys [abstract]. Circulation. 1996;94(suppl 1):1-265.
12. Honore EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril. 1997; 67:148-154.
13. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276-282.
14. Sirtori CR, Gatti E, Mantero O, et al. Clinical experience with the soybean protein diet in treatment of hypercholesterolemia. Am J Clin Nutr. 1979;32:1645-1658.
15. Goldberg AP, Lim A, Kolar JB, Grundhauser JJ, Steinke FH, Schonfeld G. Soybean protein independently lowers plasma cholesterol levels in primary hypercholesterolemia. Atherosclerosis. 1982;43:355-368.
16. Sirtori CR, Zucchi-Dentone C, Sirtori M, et al. Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in type II hyperlipidemic patients. Ann Nutr Metab. 1985;29:348-357.
17. Verrillo A, de Teresa A, Giarrusso PC, LaRocca S. Soybean protein diets in the management of type II hyperlipoproteinaemia. Atherosclerosis. 1985;54:321-331.
18. Gaddi A, Ciarrocchi A, Matteucci A, et al. Dietary treatment for familial hypercholesterolemia: differential effects of dietary soy protein according to the apolipoprotein E phenotypes. Am J Clin Nutr. 1991;53:1191-1196.
19. Laurin D, Jacques H, Moorjani S, et al. Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia. Am J Clin Nutr. 1991; 54:98-103.
20. Widhalm K, Brazda G, Schneider B, Kohl S. Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolemia. J Pediatr. 1993;123:30-34.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
22. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data based approach to diet questionnaire design and testing. Am J Epidemiol. 1986; 124:453-469.
23. Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet recdords. J Clin Epidemiol. 1990;43: 1327-1335.
24. King JM, Crouse JR, Terry JG, Morgan TM, Spray BJ, Miller NE. Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia. Am J Med. 1994;97:323-331.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
26. Coward L, Barnes NC, Setchell KDR, Barnes S. Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J Agr Food Chem. 1993;41:1961-1967.
27. Carroll KK. Review of clinical studies on cholesterol-lowering response to soy protein. J Am Diet Assoc. 1991;91:820-827.
28. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr. 1995;125(suppl):606S-611S.
29. Adlercreutz H, Hämäläinen E, Gorbach S, Goldin B. Dietary phyto-oestrogens and the menopause in Japan [letter]. Lancet. 1992;339:1233.
30. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-941.
31. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995; 273:199-208.
32. Sullivan JM, Fowlkes LP. Estrogens, menopause, and coronary artery disease. Cardiol Clin. 1996;14:105-116.
33. Kim CJ, Ryu WS, Kwak JW, Park CT, Ryoo UH. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy. Arch Intern Med. 1996;156:500-504.
34. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol. 1997;17:3392-3398.
35. Sirtori CR, Gianazza E, Manzoni C, Lovati MR. Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. Am J Clin Nutr. 1997;65:166-167.
36. Knopp, RH, Walden CE, Retzlaff BM, et al. Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. JAMA. 1997;278:1509-1515.
37. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause. 1999;6:7-13.